据FDA所说，顺尔宁的网站上包含了有关顺尔宁最新的处方信息以及病人资料。
Singulair's web site includes the most current prescribing information and patient information for Singulair, according to the FDA.
顺尔宁是默克公司去年在美国销售额最大的以及最被推荐使用的呼吸系统药物，…
Singulair was Merck's biggest product last year and the most-prescribed respiratory drug in the U. S. , …
与此同时，FDA呼吁顺尔宁是“有效”的，并劝告有病的患者在未与自己的医生交流之前不要停止服用顺尔宁。
Meanwhile, the FDA calls Singulair "effective" and advises patients with questions not to stop taking Singulair before talking to their doctor.
结论顺尔宁口服作为婴幼儿喘息性支气管炎辅助治疗方法不仅安全，而且疗效确切，可缩短患儿住院时间，改善预后效果。
Conclusion Singulair is safe, efficient in treating infant asthmatic bronchitis as adjuvant therapy. And it can obviously shorter the hospitalized time and improve the prognosis.
结论顺尔宁口服作为婴幼儿喘息性支气管炎辅助治疗方法不仅安全，而且疗效确切，可缩短患儿住院时间，改善预后效果。
Conclusion Singulair is safe, efficient in treating infant asthmatic bronchitis as adjuvant therapy. And it can obviously shorter the hospitalized time and improve the prognosis.
应用推荐